Nitika Dabas is a Cardiology physician. OpenAlex indexes 12 publications with 602 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
946 Bloomfield Ave
Glen Ridge, NJ 070281308
Telephone
973-743-1121Provider last certified this registry record 25 Oct 2023.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202534 payments
- Biosense Webster, Inc.Program year202523 payments
- Boston Scientific CorporationProgram year202515 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
73.7%Beta blocker23.7%Metoprolol Succinate74%Carvedilol16%Metoprolol Tartrate10%Part D<11 patientsCalcium channel blocker9.4%Amlodipine Besylate62%Diltiazem 24hr Er (Cd)38%Part D≥23 patients+ 8 more classes in this area
Blood & clotting
26.3%Factor Xa inhibitor20.8%Eliquis78%Xarelto22%Part D≥48 patientsP2Y12 inhibitor3.4%Clopidogrel100%Part D≥15 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Long-term cardiac surveillance and outcomes of COVID-19 patients
Trends in Cardiovascular Medicine
2022 - Trastuzumab-induced cardiotoxicity: a review of clinical risk factors, pharmacologic prevention, and cardiotoxicity of other HER2-directed therapies
Breast Cancer Research and Treatment
2021 - OUTCOMES OF LEADLESS PACING ON TRICUSPID VALVE AND RIGHT VENTRICULAR FUNCTION
Journal of the American College of Cardiology
2021 - AN UNCOMMON COMMON PROCEDURE: VENTRICULAR ANEURYSMECTOMY IN CHAGAS CARDIOMYOPATHY
Journal of the American College of Cardiology
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”